Andrzej Dekundy
Frankfurt Am Main, HE 60318, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Amantadine for Traumatic Brain Injury-Supporting Evidence and Mode of Action.
Journal: Biomedicines
Published: June 27, 2024
Improvement in Quality-of-Life-Related Outcomes Following Treatment with IncobotulinumtoxinA in Adults with Limb Spasticity: A Pooled Analysis.
Journal: Toxins
Published: October 16, 2023
Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Lower Limb Spasticity in Japanese Subjects.
Journal: Frontiers in neurology
Published: December 10, 2021
IncobotulinumtoxinA for Post-stroke Upper Limb Spasticity in Neutralizing Antibody-positive Patients after Botulinum Toxin Therapy: A Report of Two Cases.
Journal: Progress in rehabilitation medicine
Published: October 01, 2021
Duration and onset of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjects.
Journal: Current medical research and opinion
Published: August 13, 2021
Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentials.
Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: October 22, 2020
IncobotulinumtoxinA for the Treatment of Blepharospasm in Toxin-Naïve Subjects: A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial.
Journal: Advances in therapy
Published: April 29, 2020
IncobotulinumtoxinA for upper- and lower-limb spasticity in Japanese patients.
Journal: Current medical research and opinion
Published: March 07, 2020
Efficacy and safety of incobotulinumtoxinA in post-stroke upper-limb spasticity in Japanese subjects: results from a randomized, double-blind, placebo-controlled study (J-PURE).
Journal: Journal of neurology
Published: December 18, 2019
Rescue of Fmr1KO phenotypes with mGluR5 inhibitors: MRZ-8456 versus AFQ-056.
Journal: Neurobiology of disease
Published: June 30, 2018
Further pharmacological characterization of eltoprazine: focus on its anxiolytic, anorexic, and adverse‑effect potential.
Journal: Acta neurobiologiae experimentalis
Published: April 06, 2017
Effects of dopamine uptake inhibitor MRZ-9547 in animal models of Parkinson's disease.
Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: July 15, 2014
Last Updated: 09/26/2026